Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Schiffrin (Montreal, Canada). Hypertension and inflammation. Research Seminar 2006 - Complexity of patients with multiple chronic diseases

Member's Comments

No comment yet.

Related content which might interest you: Endothelial dysfunction, biology and oxidative stress in PAH Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension Year: 2005 Development of new treatments for complex chronic comorbidities Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Food and nutrient intake, oxidative stress biomarkers and respiratory outcomes in Chileans Source: Annual Congress 2005 - Highlights of asthma epidemiology Year: 2005 Biomarkers of lipid peroxidation, airway inflammation and asthma Source: Eur Respir J 2003; 21: 177-186 Year: 2003 COPD: inflammatory mechanisms and systemic consequences Source: Eur Respir Mon 2013; 59: 13-27 Year: 2013 The role of inflammation in cachexia Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Carbonyl stress and enhanced macrophage function Source: Annual Congress 2005 - Oxidative and nitrative stress: control of cell function in COPD Year: 2005 Oxidative stress in lung cell physiology Source: Annual Congress 2006 - Physiological year in review Year: 2006 Does systemic inflammation trigger local exercise-induced oxidative stress in COPD? Source: Eur Respir J 2004; 23: 538-544 Year: 2004 Metabolomics profiling identifies female-selective upregulation of oxidative stress in individuals with COPD Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction Source: Eur Respir J 2008; 31: 1334-1356 Year: 2008 Implications for disease and therapy Source: Annual Congress 2005 - Oxidative and nitrative stress: control of cell function in COPD Year: 2005 Role of anti-proliferative therapy in PAH Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008 Overnight urinary isoprostane levels during CPAP withdrawal as a marker of oxidative stress Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016 Oxidative stress and inflammation in OSA Source: Eur Respir Mon 2010; 50: 360-380 Year: 2010 Profile of systemic oxidative stress markers and effect on skeletal muscle function in COPD Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity Year: 2013 The dietary antioxidant quercetin reduces markers of oxidative stress and inflammation in sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 110s Year: 2007 PAH and inflammation: its role in pathogenesis - is it of value to modulate it? Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension Year: 2005 Eucalyptol reduced inflammation and oxidative stress on mouse lungs exposed to long and short-term cigarette smoke Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 Drug-induced pulmonary toxicity: a role for anti-oxidants in oxidative stress Source: Annual Congress 2009 - PG7 Drug-induced pulmonary toxicity Year: 2009